Healthcare
Live Price
Offline$0.05
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Reflect Scientific, Inc. (RSCF) is a Healthcare stock with listed on OTC. The stock last traded around $0.05 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of -14.0%, EPS growth of +20.0%, a dividend yield of 0.0%. What stands out right now is revenue -14.0%, EPS +20.0%, free cash flow 0.0% with operating margin 10.3% and ROIC 7.0%. Valuation is more restrained than many high-expectation growth names at P/E 16.3 and price/sales 2.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RSCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RSCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RSCF Max Drawdown
-51.75%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RSCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$2.8M
+37.9% YoY
FY Net Income
$939.1K
+950.5% YoY
Free Cash Flow
$335.9K
+1431.9% YoY
Revenue Growth
-14.0%
EPS Growth
+20.0%
Gross Margin
34.6%
Net Margin
13.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2M | 2M | 1M | 2M | 3M |
| Gross Profit | 559K | 558K | 596K | 1M | 2M |
| Operating Income | 167K | 131K | -467K | 90K | 828K |
| EBITDA | 247K | 242K | -406K | 146K | 885K |
| Net Income | 210K | 169K | -459K | 89K | 939K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2M | 1M | 1M | 1M | 1M |
| Total Assets | 3M | 2M | 3M | 2M | 2M |
| Total Liabilities | 535K | 251K | 776K | 150K | 299K |
| Shareholder Equity | 2M | 2M | 2M | 2M | 2M |
| Total Debt | 105K | 196K | 243K | 57K | 114K |
| Net Debt | -2M | -818K | -1M | -1M | -1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
336K
+1431.9% YoY
Capital Expenditures
0
Free Cash Flow
336K
+1431.9% YoY
Key ratios
Gross Margin
34.6%
Operating Margin
10.3%
Net Margin
13.0%
ROE
9.7%
Debt / Equity
0.05x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.